Skip to main content
Equibles

FMR LLC

Position in RAPP — Rapport Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$298,894,492
+$74,578,391 QoQ
Shares Held
7,172,894
+0.1% QoQ
Ownership
15.0%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 159 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. RAPP ranks #50 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in RAPP

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $298,894,492 7,172,894
2026-03-31 $224,316,101 7,168,939
2025-12-31 $215,773,984 7,111,865
2025-09-30 $205,434,751 6,916,995
2025-06-30 $62,246,576 5,474,633
2025-03-31 $55,029,273 5,486,468
2024-12-31 $97,329,942 5,486,468
2024-09-30 $112,362,864 5,486,468
2024-06-30 $115,912,743 4,983,351